Treatment for low-PSA mHSPCa - Advanced Prostate...

Advanced Prostate Cancer

22,262 members27,955 posts

Treatment for low-PSA mHSPCa

Purple-Bike profile image
7 Replies

Does anyone have a clue for treatment of low-PSA metastatic PCa? For neuroendocrine PCa?

The only study I can find on treatment for low-PSA: "Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis | Oncology | JAMA Network Open"

| indicates that adding docetaxel to SOC for low-PSA patients had very good results, however this was for non-metastatic advanced localized disease.

From European Urology Volume 74, Issue 2, August 2018, Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer

"For Gleason 8–10 tumors, PSA ≤2.5 ng/ml was associated with higher expression of neuroendocrine/small-cell markers compared to >2.5 ng/ml (p = 0.046), with no such relationship for Gleason ≤7 disease".

Written by
Purple-Bike profile image
Purple-Bike
To view profiles and participate in discussions please or .
Read more about...
7 Replies
GP24 profile image
GP24

You do not seem to have neuroendocrine PCa, so why do you ask?

The usual threapy is a chemo with carboplatin combined with e.g. cabazitaxel: ncbi.nlm.nih.gov/pmc/articl...

This study reports success with metastases directed therapy for neuroendocrine PCa: ncbi.nlm.nih.gov/pmc/articl...

Finally, Himisha Beltran and Martin Bakht found that some neuroendocrine PCa has PSMA expression. So if a PSMA PET/CT shows PSMA positive lesions you could try Lutetium 177 therapy. (Experimental) urotoday.com/video-lectures... and pubmed.ncbi.nlm.nih.gov/315...

Tall_Allen profile image
Tall_Allen

"Does anyone have a clue for treatment of low-PSA metastatic PCa? For neuroendocrine PCa? "

Is that your diagnosis? Which one do you have - low-PSA metastatic PCa or neuroendocrine PCa or both? How was it diagnosed?

Purple-Bike profile image
Purple-Bike in reply toTall_Allen

CT and Bone Scan show two focal uptakes, with more precision from DCF-Pyl-PET and NaF-PET scans that are to be made within three days when I will also get a set of tests to indicate whether my low-PSA score is likely to be associated with neuroendocrine disease.

May I change focus…..? MO did not order an FDG-PET scan, but the passages below make me think this could be a mistake. Should I insist?

Posted by V10fanatic: “My recent PSMA-PET came back clear with a PSA of 4, so my MO suggested I run an FDG. It found 4 mets; my spine(2), rib, and pelvis. He said that maybe 10% of metastatic men fall into the discordant realm”.

From A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer J Nucl Med 2022; 63:735–741 DOI: 10.2967/jnumed.121.262371

“In about 10% of men, some lesions were positive on-FDG and negative on DCFPyL, despite an overall higher lesion number seen on DCFPyL, implying that a limited number of metastases may exhibit aggressive metabolic features with low PSMA (FDG+, PSMA–) earlier in the course of disease (22). Indeed, similar to the study by Wang et al. (23), we noted discordance between the 2 scans with 22 of 322 lesions detected by-FDG alone in 8 of 30 patients (27%), of which 3 were CRPC and 5 were CSPC. These lesions may be clinically relevant, as decreased survival and therapeutic response have been noted in men with abnormal FDG PET findings (21, 22,24,25)”.

Tall_Allen profile image
Tall_Allen in reply toPurple-Bike

Why? Are you getting Pluvicto?

Leaffan57 profile image
Leaffan57

I’m low volume metastatic… getting ADT and Erleada

Purple-Bike profile image
Purple-Bike

LU-177 J591 is one of the options I am considering.

But even if I will not use that therapy, surely an FDG PET scan will be crucial, if lesions unique to FDG-PET are discovered, given that I will use SBRT for local control?

It is only 10% of men who have lesions only shown on FDG-PET, but I could be one of those 10 % and it also seems that those kinds of lesions are of higher potential lethality.

Purple-Bike profile image
Purple-Bike

Unfortunately, there was no comparison between FDG-PET and NaF-PET, which might have been more interesting given that neither need PSMA-expressing cancer cells for detection. Perhaps the 10 % figure would be much smaller in such a comparison, so that it is not worth worrying about, given that I will have both NaF-PET and DCF-Pyl..... Also the CT scan, FWIW, detects non-PSMA avid cells.

Not what you're looking for?

You may also like...

Low PSA with High Grade Cancer (Gleason 9)

The American Society of Clinical Oncology has reported that patients with Gleason 8 to 10 cancer...
Gleason4042 profile image

High Gleason low PSA - quit ADT?

Diagnosed with Gleason 9, PSA 1.7 two months ago and adding to the replies to GabF:s post a day ago...
Purple-Bike profile image

Low PSA at diagnosis.

New study below [1]. In 2002, at age 54, a DRE discovered a nodule on my prostate. PSA was 0.8....
pjoshea13 profile image

Low PSA levels are associated with greater prostate cancer-specific mortality among men with a Gleason score of 8 to 10

Conclusions: Among patients with high-grade disease, patients with PSA levels ≤ 2.5 ng/mL or PSA...

PSA Rising Dx 06/2022 PSA 864.42 to 01/2023 <0.06 now no longer undetectable, I won’t see DR until next month, What will the Dr do?

Diagnosed 07/01/2022 PSA 942.40 Gleason 8 ductal without large cribform gland / Gleason 9 4+5...